News
Centenarian Blood and the Science of Longevity
February 28, 2026

Centenarian Blood and the Science of Longevity

A recent article published by the Faculty of Medicine at the University of Geneva (UNIGE) highlights research exploring the biological mechanisms of longevity, based on the analysis of proteins circulating in the blood of centenarians.

This work was conducted by the former research team of Professor Karlheinz Krause, now President of the Fondation pour Recherches Médicales, in collaboration with the late Professor François Herrmann, a leading figure in geriatric medicine in Geneva.

Understanding the biology of healthy aging

The study focuses on the role of circulating factors in the bloodstream and how they may influence biological processes associated with aging. By analyzing the protein profiles of individuals who have reached exceptional longevity, researchers aim to identify mechanisms that support healthy and resilient aging.

These findings contribute to a better understanding of the complex interactions between the immune system, metabolism, and cellular pathways involved in longevity.

From fundamental science to translational research

This research illustrates the long-term impact of fundamental biomedical science and its potential to inform translational approaches aimed at improving prevention and treatment of age-related diseases.

It also reflects the scientific legacy of Professor François Herrmann, whose contributions to research in aging and geriatrics have had a lasting influence on the Geneva medical community.

🔗 Read the full article published by the UNIGE Faculty of Medicine:
https://www.unige.ch/medecine/faculteetcite/media/le-sang-des-centenaires-eclaire-les-mecanismes-de-la-longevite

🔗 Learn more about the life and legacy of Professor François Herrmann:
https://www.unige.ch/lejournal/trajectoires/hommages/2026/francois-herrmann/

Photo credit : © SWISS100/Jos Schmid. Les scientifiques ont comparé le sang de centenaires à celui d'octogénaires, puis d'adultes âgé-es entre 30 et 60 ans.

BACK TO our news